Free Trial
→ SpaceX will mint billionaires. You won't be one of them. (From Behind the Markets) (Ad)tc pixel Free TRUMY Stock Alerts

Terumo (TRUMY) Stock Forecast & Price Target

Terumo logo
$13.75 -0.50 (-3.51%)
As of 06/12/2026 03:58 PM Eastern
Compare

Terumo - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold
Based on 2 Analyst Ratings
Sell
0
Hold
2
Buy
0

Based on 2 Wall Street analysts who have issued ratings for Terumo in the last 12 months, the stock has a consensus rating of "Hold." Out of the 2 analysts, 2 have given a hold rating for TRUMY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for TRUMY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Terumo and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRUMY Analyst Ratings Over Time

TypeCurrent Forecast
6/13/25 to 6/13/26		1 Month Ago
5/14/25 to 5/14/26		3 Months Ago
3/15/25 to 3/15/26		1 Year Ago
6/13/24 to 6/13/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
 N/A
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
 N/A
Hold
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
 N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
 N/A
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus RatingHoldHoldHoldN/A

TRUMY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TRUMY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Terumo Stock vs. The Competition

TypeTerumoMedical CompaniesBroader Market
Consensus Rating Score
2.00
2.29
2.52
Consensus RatingHoldHoldModerate Buy
Predicted UpsideN/A694.96% Upside13.95% Upside
News Sentiment Rating
Neutral News

See Recent TRUMY News
Positive News
Positive News
Export
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
4/9/2026
Zacks Research logo
Zacks Research
Not Rated
 UpgradeHold
2/24/2026
Nomura logo
Nomura
5 of 5 stars
 UpgradeHold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:59 PM ET.


Should I Buy Terumo Stock? TRUMY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, June 8, 2026. Please send any questions or comments about these Terumo pros and cons to contact@marketbeat.com.

Terumo
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Terumo Co.:

  • The current stock price is around $18, which may present a buying opportunity for investors looking for value in the healthcare sector.
  • Recent increases in short interest indicate growing investor interest, which can lead to increased volatility and potential for price appreciation.
  • With a relatively low short percentage of float, there may be less risk of a short squeeze, allowing for more stable price movements.
  • The average daily trading volume has shown an upward trend, suggesting increased liquidity and interest in Terumo Co.'s shares.
  • Institutional ownership is currently at 0%, which may indicate potential for future investment from larger entities as the company grows.

Terumo
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Terumo Co. for these reasons:

  • There has been no significant change in the company's performance over the past year, which may indicate stagnation.
  • The company has a high level of short interest, which could lead to increased volatility and risk for investors.
  • Outstanding shares are currently reported as zero, which raises questions about the company's share structure and market presence.
  • Institutional ownership is at 0%, suggesting a lack of confidence from larger investors, which could be a red flag for potential investors.
  • The month-to-month change in short interest shows only a slight increase, indicating that investor sentiment may not be improving significantly.

TRUMY Forecast - Frequently Asked Questions

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Terumo in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TRUMY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRUMY, but not buy additional shares or sell existing shares.

According to analysts, Terumo's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, Terumo's stock had 1 upgrade by analysts.

Terumo has been rated by research analysts at Zacks Research in the past 90 days.

Analysts like Terumo less than other "medical" companies. The consensus rating score for Terumo is 2.00 while the average consensus rating score for "medical" companies is 2.29. Learn more on how TRUMY compares to other companies.

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Terumo Recommendations


This page (OTCMKTS:TRUMY) was last updated on 6/13/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever
"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...
Chaikin Analytics | Sponsoredtc pixel